Friday, 30 September 2005 (Hall A) 08:30-10:30

Keynote Session

     EMVBM logos indicate Young Investigator Award Nominees     
Keynote Address and Young Investigator Award Competition

Chairpersons: A.C. Newby (Bristol, GB), J.D. Pearson (London, GB)

(K228) Angiogenesis-based biomarkers: Can cancer be treated before it can be anatomically located?

J. Folkman (Boston MA, US)
(O229) Atherosclerotic lesions with exaggerated inflammation show impaired collagen maturation.
O. Ovtchinnikova, A-K. Robertson, G.K. Hansson (Stockholm, SE)
(O230) Antibody conjugated near infrared dye detects focal atherosclerotic lesions in ApoE deficient mice.
M. Roser, Chr. Perlitz, M. Gräfe, T. Dietrich, K. Atrott, Ph. Stawowy, E. Nagel, E. Fleck, M. Schirner, K. Graf (Berlin, DE)
(O231) The oxidative phosphorylation pathway is differentially regulated between macrophages microdissected from early and advanced atherosclerotic lesions.
N. Kisters, M. Faessen, J.O. Fledderus, O.L. Volger, K.B. Cleutjens, M.J. Daemen, A.P. Bijnens (Maastricht and Amsterdam, NL)
(O232) Evidence of systemic and pulmonary endothelial dysfunction in the Dimethylarginine Dimethylaminohydrolase I (DDAH I+/-) heterozygous knockout mouse.
M. Malaki, M. Nandi, M. Madhani, H. Gill, C. Smith, J. Leiper, P. Vallance (London, GB)
(O233) Protective role of B7 and CD28 co-stimulatory molecules in the development of atherosclerosis.
S. Potteaux, H. Ait Oufella, B. Salomon, B. Esposito, D. Klatzmann, P. Ardouin, A. Tedgui, Z. Mallat (Paris and Villejuif, FR)